Somerset Indus Closes $288M Fund III for Healthcare Impact

Somerset Indus Capital Partners has successfully closed its third fund at nearly USD 288 million, surpassing the planned USD 250 million, reflecting strong investor confidence in its healthcare-focused, impact-driven strategy.

The oversubscribed Fund III attracted a diverse mix of global institutional investors, including development finance institutions, investment firms, insurers, and family offices from Europe, the US, and Southeast Asia.

High re-up rates from existing backers, alongside new marquee investors, highlight faith in Somerset’s “Capital for Change” approach. The fund will focus on addressing India’s healthcare access gap for the “missing middle,” particularly in Tier II and Tier III cities.

Also Read: DrStore Healthcare launched a platform to track outcomes of GLP-1

Capital will be deployed in scalable businesses across healthcare delivery, pharmaceuticals, diagnostics, medical devices, and allied sectors, with investment sizes typically ranging from USD 15–40 million and the ability to co-invest up to USD 60–80 million for larger opportunities.

Fund III is already active with three investments: Cyrix Healthcare, Printmann Offset, and NU Hospitals, each showing early positive performance.

Somerset aims to drive transformative growth in preventive care, OPD-linked insurance, healthcare financing, embedded insurance, generics, MedTech innovation, and diagnostics platforms to expand access beyond metro markets.

Somerset’s track record reinforces investor confidence: Fund I delivered roughly 4.0x DPI, while Fund II is approaching exits, with the first realization in September 2025 achieving approximately 4x MOIC.

Also Read: MGM Healthcare Launches Swayam: Chennai's Top Geriatric Programme

According to Avinash Kenkare and Mayur Sirdesai, partners at Somerset, Fund III positions the firm to deepen its presence in underserved markets and partner with entrepreneurs building scalable healthcare platforms, delivering measurable social impact alongside sustainable financial returns.